buserelin


Also found in: Wikipedia.

buserelin

A long-acting GnRH-gonadotropin-releasing hormone analogue, which causes permanent pitutary stimulation and downregulates the pituitary-gonadal axis, blocking testosterone production in the testes; it has been used to treat metastatic prostate and breast cancer, to create pseudomenopause to reduce the size and number of endometriotic lesions and fibroids. It has also been used for hirsutism, to induced ovulation and for in vitro fertilisation.

buserelin

Suprefact® Infertility A long-acting gonadotropin-releasing hormone analogue which downregulates the pituitary-gonadal axis, block testosterone production in the testes; it has been used to treat metastatic prostate CA. See Disease flare.

buserelin

A gonadothropin-releasing hormone drug used in the treatment of ENDOMETRIOSIS and INFERTILITY. Brand names are Suprecur and Suprefact.
Mentioned in ?
References in periodicals archive ?
Contract notice: Conclusion of non-exclusive discount agreements pursuant to 130a (8) sgb v on medicines containing the active substance buserelin (atc: L02ae01) as part of a so-called open-house model.
Conventional LHRH agonists currently available on the market include leuprolide acetate, buserelin, goserelin, and triptorelin, each available in depot formulations requiring monthly, three-monthly, four-monthly, or longer-duration injections.
Izmedu nekoliko agonista gonadotropnog otpustajuceg hormona najcesce se koriste buserelin 0,5 mg, triptorelin 0,2 mg i leuprolid (0,5-4 mg).
5 mg of buserelin, Suprefact, Serono), on day 21 of their menstrual cycle (1 wk before the expected menses).
1 mg of subcutaneous Buserelin Acetate (Suprefact) was initiated on day 21 to achieve adequate ovarian suppression, followed by recombinant FSH (Gonal-f) or hMG (Menogon).
Ovulation induction was achieved with Metrodin HP (150-225 IU), following a long protocol of pituitary desensitization with Buserelin acetate (stimulation lasted 8 days, from third day until the tenth day of menstrual cycle).
GnRH agonists, such as buserelin and triptorelin, have been used to induce remission of symptoms by causing ovarian suppression.
Progesterone-induced urticaria: response to buserelin.
5 ml, Buserelin acetate, Gynarich (b)) on the day of start of synchronization (0 day), 500 [micro]g of [PGF.
Plasma total cholesterol, total glyceride, low density lipoprotein cholesterol (LDL-C), leptin, and glucose levels were significantly decreased after treatment with T occidentalis, [alpha]-thujone, or reference buserelin acetate, when compared to the control group.
In the long protocol, the ovary was suppressed with gonadotrophin-releasing hormone analog (GnRH-a) Buserelin (CinnaFact, Laboratory, Cinnagen, Iran) therapy, starting from the mid-luteal phase of the previous menstrual cycles.
Analogs of GnRH have been synthesized since the 1970s, and buserelin, nafarelin, leuprolide, and triptorelin are some common analogs of GnRH.